Table:
begin	end	state
1	19	non-cytoplasmic
20	40	transmembrane
41	44	cytoplasmic
45	71	transmembrane
72	107	cytoplasmic
108	133	transmembrane
134	144	non-cytoplasmic
145	187	transmembrane
188	202	non-cytoplasmic
203	223	transmembrane
224	255	cytoplasmic
256	279	transmembrane
280	315	non-cytoplasmic
316	341	transmembrane
342	352	cytoplasmic
353	381	transmembrane
382	386	non-cytoplasmic
387	387	cytoplasmic
388	406	transmembrane
407	416	cytoplasmic
417	443	transmembrane
444	463	non-cytoplasmic
464	487	transmembrane
488	500	cytoplasmic

Input:
>RR42_RS15180
MELLANLGLGFSTALTLQNLAYAFLGCVLGTLIGVLPGLGPLATIAMLLPVTYTLPPVAA
LIMLAGIYYGAQYGGSTTAILVNLPGESSSVVTTIDGYQMARRGRAGVALATAGLGSFFA
GCVATLILAAFAAPLSELAFKFGPAEYFSLMVLGLIGAVVLASGSLVKAIAMIVLGLLLG
LVGTDVNSGAARFSFDVPELTDGLNFVSVAMGVFGFAEIIANLEQKDARETFTDHITNLF
PTKADFKRMIPAVLRGTFLGSALGILPGGGAALASFAAYSLEKKTSKFSHEFGKGAIEGV
AGPESANNAAAQTSFIPLLTLGIPPNAVMALMVGAMTIHNIQPGPQVMTSNPALFWGLIA
SMWIGNFMLIILNLPLIGIWVKLLKVPYRYLYPAILVFCCIGVYSVQNTTFDVFQTAAFG
VIGYLFIKLKCEPAPLLLGFVLGPMMEENFRRSLLLSRGEFSVFLTRPLSLGLLIAAAVL
VLIVALPSIKNKREEAFQEE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server